Search for: "Teva USA"
Results 281 - 300
of 714
Sorted by Relevance
|
Sort by Date
17 May 2007, 9:09 am
Teva Pharmaceuticals USA Inc., No. 06-0282, 22 BNA Toxic Law Rptr. #20 (S.D. [read post]
17 Sep 2015, 4:59 pm
Teva Pharmaceuticals USA, Inc. v. [read post]
18 Jul 2018, 11:23 am
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
2 Oct 2013, 8:58 am
Teva Pharmaceuticals USA et al. [read post]
29 Mar 2016, 7:21 am
Reinstein agreed to switch his patients to the generic version, but only after its manufacturers, Teva Pharmaceuticals USA Inc. and IVAX Pharmaceuticals LLC, agreed to pay him a consulting fee and finance a Clozapine research study performed by a Reinstein-affiliated entity. [read post]
12 Jun 2014, 8:48 pm
USA, Inc., No. 2013-1306 (Fed. [read post]
17 Mar 2015, 7:49 pm
USA, Inc. v. [read post]
25 Jun 2018, 7:03 am
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
5 Apr 2012, 1:41 pm
When Teva went to FDA to seek clarification as to 180-day exclusivity for generic PROVIGIL, however, Teva says that the Agency “signaled its belief that Teva USA may not be entitled to such exclusivity. [read post]
2 Jun 2014, 7:48 am
Teva Pharm. [read post]
14 Apr 2014, 3:51 pm
— filed their opposition to a plea by Teva that seeks to block the generic alternatives of its drug Copaxone, at least while the Supreme Court moves ahead with review of a pending appeal by Teva seeking to revive its key patent on that drug (Teva Pharmaceuticals USA v. [read post]
18 Sep 2019, 6:35 am
Teva was down almost 15 percent, Mylan fell by nine percent, and Lannett LCI dropped by 19 percent. [read post]
31 Jan 2019, 8:32 am
TEVA Pharmaceuticals USA INC., et al., had the opportunity to interpret the Leahy-Smith America Invents Act (AIA) with respect to how this impacts on the issue of the novelty of an invention. [read post]
27 Jan 2020, 7:42 am
Teva Pharm. [read post]
22 Jan 2019, 8:28 am
Teva Pharma USA (Supreme Court 2019) The Supreme Court has affirmed the Federal Circuit’s interpretation of the “on sale bar” — holding that “Congress did not alter the meaning of ‘on sale’ when it enacted the AIA. [read post]
17 Feb 2010, 8:00 am
Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2009, 9:45 am
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
